Cargando…
Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study
BACKGROUND: In 2021, we showed an increased risk associated with COVID-19 in pregnancy. Since then, the SARS-CoV-2 virus has undergone genetic mutations. We aimed to examine the effects on maternal and perinatal outcomes of COVID-19 during pregnancy, and evaluate vaccine effectiveness, when omicron...
Ejemplares similares
-
Preeclampsia and COVID-19: results from the INTERCOVID prospective longitudinal study
por: Papageorghiou, Aris T., et al.
Publicado: (2021) -
Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study
por: Giuliani, Francesca, et al.
Publicado: (2022) -
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study
por: Villar, José, et al.
Publicado: (2021) -
Diabetes mellitus, maternal adiposity, and insulin-dependent gestational diabetes are associated with COVID-19 in pregnancy: the INTERCOVID study
por: Eskenazi, Brenda, et al.
Publicado: (2022) -
INTERCOVID prospective longitudinal study: preeclampsia and COVID-19
por: Desseauve, David, et al.
Publicado: (2022)